1887

Journal of General Virology header logo

Volume 102, Issue 1

Absence of classical and atypical (H- and L-) BSE infectivity in the blood of bovines in the clinical end stage of disease as confirmed by intraspecies blood transfusion Open Access

Abstract

While the presence of bovine spongiform encephalopathy (BSE) infectivity in the blood of clinically affected sheep has been proven by intraspecies blood-transfusion experiments, this question has remained open in the case of BSE-affected cattle. Although the absence of infectivity can be anticipated from the restriction of the agent to neuronal tissues in this species, evidence for this was still lacking. This particularly concerns the production and use of medicinal products and other applications containing bovine blood or preparations thereof. We therefore performed a blood-transfusion experiment from cattle in the clinical end stage of disease after experimental challenge with either classical (C-BSE) or atypical (H- and -) BSE into calves at 4–6 months of age. The animals were kept in a free-ranging group for 10 years. Starting from 24 months post-transfusion, a thorough clinical examination was performed every 6 weeks in order to detect early symptoms of a BSE infection. Throughout the experiment, the clinical picture of all animals gave no indication of a BSE infection. Upon necropsy, the brainstem samples were analysed by BSE rapid test as well as by the highly sensitive Protein Misfolding Cyclic Amplification (PMCA), all with negative results. These results add resilient data to confirm the absence of BSE infectivity in the donor blood collected from C-, H- and -BSE-affected cattle even in the final clinical phase of the disease. This finding has important implications for the risk assessment of bovine blood and blood products in the production of medicinal products and other preparations.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): blood transfusion , BSE , BSE infectivity , cattle and medicinal products
© 2021 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001460
2020-06-26
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/102/1/vir001460.html?itemId=/content/journal/jgv/10.1099/jgv.0.001460&mimeType=html&fmt=ahah

References

  1. Bellworthy SJ, Hawkins SAC, Green RB, Blamire I, Dexter G et al. Tissue distribution of bovine spongiform encephalopathy infectivity in Romney sheep up to the onset of clinical disease after oral challenge. Vet Rec 2005; 156:197–202 [View Article] [PubMed]
     [Google Scholar]
  2. Hoffmann C, Ziegler U, Buschmann A, Weber A, Kupfer L et al. Prions spread via the autonomic nervous system from the gut to the central nervous system in cattle incubating bovine spongiform encephalopathy. J Gen Virol 2007; 88:1048–1055 [View Article] [PubMed]
     [Google Scholar]
  3. Franz M, Eiden M, Balkema-Buschmann A, Greenlee J, Schatzl H et al. Detection of PrP(Sc) in peripheral tissues of clinically affected cattle after oral challenge with bovine spongiform encephalopathy. J Gen Virol 2012; 93:2740–2748 [View Article] [PubMed]
     [Google Scholar]
  4. González L, Pitarch JL, Martin S, Thurston L, Simmons H et al. Influence of polymorphisms in the prion protein gene on the pathogenesis and neuropathological phenotype of sheep scrapie after oral infection. J Comp Pathol 2014; 150:57–70 [View Article] [PubMed]
     [Google Scholar]
  5. Garza MC, Monzón M, Marín B, Badiola JJ, Monleón E. Distribution of peripheral PrP(Sc) in sheep with naturally acquired scrapie. PLoS One 2014; 9:e97768 [View Article] [PubMed]
     [Google Scholar]
  6. Wells GA, Hawkins SA, Green RB, Austin AR, Dexter I et al. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 1998; 142:103–106 [View Article] [PubMed]
     [Google Scholar]
  7. Wells GAH. Pathogenesis of BSE. Vet Res Commun 2003; 27 Suppl 1:25–28 [View Article] [PubMed]
     [Google Scholar]
  8. Buschmann A, Groschup MH. Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J Infect Dis 2005; 192:934–942 [View Article] [PubMed]
     [Google Scholar]
  9. Balkema-Buschmann A, Fast C, Kaatz M, Eiden M, Ziegler U et al. Pathogenesis of classical and atypical BSE in cattle. Prev Vet Med 2011; 102:112–117 [View Article] [PubMed]
     [Google Scholar]
  10. Kaatz M, Fast C, Ziegler U, Balkema-Buschmann A, Hammerschmidt B et al. Spread of classic BSE prions from the gut via the peripheral nervous system to the brain. Am J Pathol 2012; 181:515–524 [View Article] [PubMed]
     [Google Scholar]
  11. Okada H, Miyazawa K, Fukuda S, Iwamaru Y, Imamura M et al. The presence of disease-associated prion protein in skeletal muscle of cattle infected with classical bovine spongiform encephalopathy. J Vet Med Sci 2014; 76:103–107 [View Article] [PubMed]
     [Google Scholar]
  12. Groschup MH, Weiland F, Straub OC, Pfaff E. Detection of scrapie agent in the peripheral nervous system of a diseased sheep. Neurobiol Dis 1996; 3:191–195 [View Article] [PubMed]
     [Google Scholar]
  13. van Keulen LJM, Bossers A, van Zijderveld F. TSE pathogenesis in cattle and sheep. Vet Res 2008; 39:24 [View Article] [PubMed]
     [Google Scholar]
  14. van Keulen LJM, Vromans MEW, Dolstra CH, Bossers A, van Zijderveld FG. Pathogenesis of bovine spongiform encephalopathy in sheep. Arch Virol 2008; 153:445–453 [View Article] [PubMed]
     [Google Scholar]
  15. Okada H, Masujin K, Iwamaru Y, Imamura M, Matsuura Y et al. Experimental transmission of H-type bovine spongiform encephalopathy to bovinized transgenic mice. Vet Pathol 2011; 48:942–947 [View Article] [PubMed]
     [Google Scholar]
  16. Suardi S, Vimercati C, Casalone C, Gelmetti D, Corona C et al. Infectivity in skeletal muscle of cattle with atypical bovine spongiform encephalopathy. PLoS One 2012; 7:e31449 [View Article] [PubMed]
     [Google Scholar]
  17. Konold T, Bone GE, Clifford D, Chaplin MJ, Cawthraw S et al. Experimental H-type and L-type bovine spongiform encephalopathy in cattle: observation of two clinical syndromes and diagnostic challenges. BMC Vet Res 2012; 8:22 [View Article] [PubMed]
     [Google Scholar]
  18. Balkema-Buschmann A, Priemer G, Ulrich R, Strobelt R, Hills B et al. Deciphering the BSE-type specific cell and tissue tropisms of atypical (H and L) and classical BSE. Prion 2019; 13:160–172 [View Article] [PubMed]
     [Google Scholar]
  19. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356:999–1000 [View Article] [PubMed]
     [Google Scholar]
  20. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83:2897–2905 [View Article] [PubMed]
     [Google Scholar]
  21. Houston F, McCutcheon S, Goldmann W, Chong A, Foster J et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008; 112:4739–4745 [View Article] [PubMed]
     [Google Scholar]
  22. McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC et al. All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLoS One 2011; 6:e23169 [View Article] [PubMed]
     [Google Scholar]
  23. Ironside JW, Head MW. Variant Creutzfeldt-Jakob disease and its transmission by blood. J Thromb Haemost 2003; 1:1479–1486 [View Article] [PubMed]
     [Google Scholar]
  24. Seed CR, Hewitt PE, Dodd RY, Houston F, Cervenakova L. Creutzfeldt-Jakob disease and blood transfusion safety. Vox Sang 2018; 113:220–231 [View Article] [PubMed]
     [Google Scholar]
  25. Sisó S, González L, Houston F, Hunter N, Martin S et al. The neuropathologic phenotype of experimental ovine BSE is maintained after blood transfusion. Blood 2006; 108:745–748 [View Article] [PubMed]
     [Google Scholar]
  26. Sisó S, Jeffrey M, Houston F, Hunter N, Martin S et al. Pathological phenotype of sheep scrapie after blood transfusion. J Comp Pathol 2010; 142:27–35 [View Article] [PubMed]
     [Google Scholar]
  27. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997; 349:99–100 [View Article] [PubMed]
     [Google Scholar]
  28. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353:183–189 [View Article] [PubMed]
     [Google Scholar]
  29. Taylor DM, Fraser JR. The potential risk of transmitting vCJD through surgery. J Hosp Infect 2000; 44:318–319 [View Article] [PubMed]
     [Google Scholar]
  30. Seitz R, von Auer F, Blümel J, Burger R, Buschmann A et al. Impact of vCJD on blood supply. Biologicals 2007; 35:79–97 [View Article] [PubMed]
     [Google Scholar]
  31. Sibbald B. UK patient first to contract vCJD via blood transfusion. CMAJ 2004; 170:1087 [View Article] [PubMed]
     [Google Scholar]
  32. Pincock S. Government confirms second case of vCJD transmitted by blood transfusion. BMJ 2004; 329:251.2 [View Article] [PubMed]
     [Google Scholar]
  33. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study. Vox Sang 2006; 91:221–230 [View Article] [PubMed]
     [Google Scholar]
  34. Bradley R. Bse transmission studies with particular reference to blood. Dev Biol Stand 1999; 99:35–40
     [Google Scholar]
  35. Dealler S. A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in the UK. Transfus Med 1996; 6:217–222 [View Article] [PubMed]
     [Google Scholar]
  36. European Commission Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3); 2011/C 73/01
  37. Balkema-Buschmann A, Ziegler U, McIntyre L, Keller M, Hoffmann C et al. Experimental challenge of cattle with German atypical bovine spongiform encephalopathy (BSE) isolates. J Toxicol Environ Health A 2011b; 74:103–109 [View Article] [PubMed]
     [Google Scholar]
  38. Hunt E, Moore JS. Use of blood and blood products. Vet Clin North Am Food Anim Pract 1990; 6:133–147 [View Article] [PubMed]
     [Google Scholar]
  39. Soldan A. Blood transfusions in cattle. In Pract 1999; 21:590–595 [View Article]
     [Google Scholar]
  40. Braun U, Kihm U, Pusterla N, Schönmann M. Clinical examination upon suspicion of bovine spongiform encephalopathy (BSE). [Article in German] Schweiz Arch Tierheilkd 1997; 139:35–41
     [Google Scholar]
  41. Braun U. Clinical signs and diagnosis of BSE. [Article in German] Schweiz Arch Tierheilkd 2002; 144:645–652
     [Google Scholar]
  42. Ackermann I, Balkema-Buschmann A, Ulrich R, Tauscher K, Shawulu JC et al. Detection of PrPBSE and prion infectivity in the ileal Peyer's patch of young calves as early as 2 months after oral challenge with classical bovine spongiform encephalopathy. Vet Res 2017; 48:88 [View Article] [PubMed]
     [Google Scholar]
  43. Ackermann I, Shawulu JC, Keller M, Fatola OI, Groschup MH et al. Exploring PMCA as a potential in-vitro alternative method to mouse bioassays for the highly sensitive detection of BSE prions. Berl Münch Tierärztl Wochensch 2018
     [Google Scholar]
  44. Morales R, Duran-Aniotz C, Diaz-Espinoza R, Camacho MV, Soto C. Protein misfolding cyclic amplification of infectious prions. Nat Protoc 2012; 7:1397–1409 [View Article] [PubMed]
     [Google Scholar]
  45. Concha-Marambio L, Pritzkow S, Moda F, Tagliavini F, Ironside JW et al. Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 2016; 8:370ra183–183 [View Article]
     [Google Scholar]
  46. Murayama Y, Ono F, Shimozaki N, Shibata H. L-Arginine ethylester enhances in vitro amplification of PrP(Sc) in macaques with atypical L-type bovine spongiform encephalopathy and enables presymptomatic detection of PrP(Sc) in the bodily fluids. Biochem Biophys Res Commun 2016; 470:563–568 [View Article] [PubMed]
     [Google Scholar]
  47. O'Connor MJ, Bishop K, Workman RG, Maddison BC, Gough KC. In vitro amplification of H-type atypical bovine spongiform encephalopathy by protein misfolding cyclic amplification. Prion 2017; 11:54–64 [View Article] [PubMed]
     [Google Scholar]
  48. Stormont C, Owen RD, Irwin MR. The B and C systems of bovine blood groups. Genetics 1951; 36:134–161
     [Google Scholar]
  49. Datta SP, Stone WH. Variation in reactivity of antigenic factors of the B blood group system of cattle. J Immunol 1963; 90:857–864
     [Google Scholar]
  50. Stormont CJ. Blood groups in animals. J Am Vet Med Assoc 1982; 181:1120–1124
     [Google Scholar]
  51. Balcomb C, Foster D. Update on the use of blood and blood products in ruminants. Vet Clin North Am Food Anim Pract 2014; 30:455–474 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001460
Loading
Absence of classical and atypical (H- and L-) BSE infectivity in the blood of bovines in the clinical end stage of disease as confirmed by intraspecies blood transfusion
J. Gen. Virol. 102, 001460 (2021); https://doi.org/10.1099/jgv.0.001460
/content/journal/jgv/10.1099/jgv.0.001460
/content/journal/jgv/10.1099/jgv.0.001460
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error